Medical Devices
Viromed Medical AG Achieves ISO 13485 Certification, Clears Path for ViroCAP® Market Launch
Viromed Medical AG's ISO 13485 certification enables independent market entry for its ViroCAP® cold plasma medical devices, positioning the company for accelerated growth in dermatology and veterinary markets starting October 2025.
Ocumetics Completes One-Month Postoperative Examinations for Revolutionary Intraocular Lens
Ocumetics Technology Corp. has completed critical one-month postoperative examinations for its innovative accommodating intraocular lens, marking a significant milestone in developing a potential vision correction solution that could eliminate the need for glasses or contact lenses.
UCLA Smart Pen Achieves 96% Accuracy in Early Parkinson's Detection
A UCLA-developed smart pen demonstrates 96.22% efficacy in detecting Parkinson's disease during early stages, potentially revolutionizing diagnosis and treatment effectiveness.
Eric Bernard Assumes CEO Role at Sonova, Marking Leadership Transition for Hearing Care Giant
Eric Bernard has officially become CEO of Sonova Holding AG, succeeding Arnd Kaldowski and taking the helm of the global hearing care solutions provider as it navigates future growth and innovation challenges.
HeartBeam Nears FDA Clearance for Revolutionary ECG Technology Set to Transform Cardiac Monitoring
HeartBeam is preparing for the commercial launch of its innovative 12-lead ECG synthesis software, which could significantly improve arrhythmia detection in both clinical and home settings pending FDA clearance expected by year-end.
Same-Day Dental Crown Technology Transforms Patient Experience and Restores Confidence
Definition Dental and Wellness Spa's adoption of same-day dental crown technology addresses the emotional and practical barriers to dental restoration, offering patients immediate confidence restoration through advanced CAD/CAM processes.
HeartBeam Advances Revolutionary ECG Technology Toward FDA Clearance and Commercial Launch
HeartBeam Inc. is preparing for the commercial launch of its innovative 12-lead ECG synthesis software for arrhythmia assessment, which could transform cardiac diagnostics in both clinical and home settings pending FDA clearance expected by year-end.
NewAge Industries Launches AdvantaSil APSPG-Max Silicone Pump Tubing for Extended Bioprocessing Performance
NewAge Industries' new AdvantaSil APSPG-Max silicone pump tubing offers approximately 300 hours of performance with reduced spallation and improved flow stability, addressing critical needs in bioprocessing applications by minimizing downtime and operational risks.
Spark Biomedical Secures Wellcome Leap Funding to Advance Women's Health Neurostimulation Technology
Spark Biomedical's recent funding from Wellcome Leap will enable FDA-style clinical trials for its OhmBody wearable neurostimulation device, which has shown promising results in reducing menstrual bleeding and symptoms, representing a significant advancement in addressing long-neglected women's health needs.
HeartBeam Develops First Cable-Free High-Fidelity ECG System for At-Home Cardiac Monitoring
HeartBeam's innovative ECG system enables comprehensive arrhythmia assessment outside clinical settings, potentially revolutionizing remote cardiac care and telemedicine.
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Scientific Advisory Board to Advance Dialysis-Like Cardiovascular Therapy
Sigyn Therapeutics has appointed Dr. Christoph Zaba, an expert in extracorporeal therapies, to its Scientific Advisory Board to support the development of Sigyn Therapy™, a novel treatment designed to reduce cardiovascular disease risk factors using existing dialysis infrastructure.
HeartBeam Develops First Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring
HeartBeam Inc. is advancing cardiac care with its innovative cable-free ECG system that enables comprehensive arrhythmia assessment outside clinical settings, addressing limitations of traditional ECG technology.
VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome
VolitionRx has signed an agreement with Werfen to evaluate its Nu.Q NETs assay for improved detection and monitoring of antiphospholipid syndrome, potentially transforming diagnosis and management for millions of patients worldwide.
HeartBeam Study Shows Comparable Accuracy to Standard ECG in Arrhythmia Detection
HeartBeam's 3D ECG system demonstrates comparable accuracy to standard 12-lead ECGs in detecting arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
Nutriband Showcases AVERSA™ Abuse-Deterrent Technology Addressing Opioid Crisis at Emerging Growth Conference
Nutriband Inc. presented its AVERSA™ abuse-deterrent transdermal technology at the August 2025 Emerging Growth Conference, projecting peak annual sales of $200 million for its fentanyl patch upon FDA approval with potential to exceed $800 million, offering a critical solution to the ongoing opioid epidemic.
HeartBeam Study Shows Comparable Accuracy Between Portable 3D ECG System and Standard 12-Lead ECG
HeartBeam Inc. reported study results demonstrating that its portable 3D ECG system achieves comparable accuracy to standard 12-lead ECGs in detecting cardiac arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
Holistix Introduces Red Light Therapy Slippers for At-Home Foot Pain Relief
Holistix International's new SKO Red Light Therapy Slippers offer a convenient, science-backed alternative to traditional foot pain treatments, potentially transforming how millions manage chronic foot conditions at home.
Izotropic Corporation Secures Exclusive U.S. Patent for AI-Powered Breast Cancer Diagnosis Technology
Izotropic Corporation has obtained the exclusive U.S. patent for computer-aided diagnosis using breast CT technology, positioning the company to address critical limitations in current breast cancer screening methods through AI-powered image analysis.
Sigyn Therapeutics Expands Cardiovascular Disease Study to Target Lipoprotein Reduction
Sigyn Therapeutics plans a clinical feasibility study of its blood purification technology that could address cardiovascular disease in high-risk patients while potentially extending lives of end-stage renal disease patients and generating significant economic impact.
HeartBeam's Portable ECG Device Enables Hospital-Level Cardiac Monitoring Outside Clinical Settings
HeartBeam's credit-card-sized FDA-cleared device synthesizes 12-lead ECGs from 3D signals, potentially transforming remote cardiac care by providing on-demand arrhythmia evaluation and integration with automated interpretation software.
HeartBeam to Showcase FDA-Cleared Cardiac Technology at Major Investor Conferences
HeartBeam Inc. executives will present the company's innovative cable-free 3D ECG technology at three September investor conferences, highlighting progress in commercializing a device that could transform remote cardiac care.
HeartBeam's Cable-Free ECG Technology Advances At-Home Cardiac Monitoring
HeartBeam's FDA-cleared portable ECG system enables patients to capture high-fidelity heart measurements at home, potentially improving early detection of arrhythmias and transforming cardiac care through convenient remote monitoring.
HeartBeam Receives FDA Clearance for Revolutionary Cable-Free ECG System
HeartBeam Inc. has obtained FDA clearance for its groundbreaking cable-free 12-lead ECG system that enables remote cardiac monitoring, potentially transforming how patients and physicians access critical arrhythmia data outside traditional clinical settings.
Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology
Izotropic Corporation's $300,000 private placement and warrant extension provides crucial working capital to advance its breast cancer imaging technology development.
HeartBeam Secures New Patents to Advance 3D ECG Technology for Remote Cardiac Monitoring
HeartBeam Inc. has strengthened its intellectual property portfolio with two new U.S. patents that enhance its innovative 3D ECG platform, positioning the company to transform remote cardiac care by enabling patients and physicians to monitor and diagnose heart conditions outside medical facilities.
Lionheart Health Named Finalist in Octane's 2025 Medical Technology Innovation Awards
Lionheart Health's recognition as a finalist in Octane's High Tech Awards highlights its breakthrough whole body regeneration chamber technology that could extend human healthspan by 20 years through AI-driven organ regeneration.
Izotropic Corporation Launches BreastCT.com to Promote Advanced Breast Cancer Detection Technology
Izotropic Corporation has launched BreastCT.com as an educational platform to raise awareness about its dedicated breast CT technology, which aims to improve cancer detection in women with dense breast tissue, potentially transforming breast cancer screening and diagnosis.
Branded Legacy, Inc. Expands into Biotech and Medical Devices with Acquisition of Bio Legacy Evaluative Group
Branded Legacy, Inc. (OTC: BLEG) has acquired Bio Legacy Evaluative Group, marking its entry into the biotech and medical devices sector with a focus on addressing global health challenges.
Lionheart Health Recognized as Top Implantable Stimulator Developer by MedTech Outlook
Lionheart Health, Inc. has been awarded the Top Implantable Stimulator Developer of the Year by MedTech Outlook for its innovative KlothoImplant™ and MicroImplant™ technologies, marking a significant advancement in medical device technology aimed at healthspan and organ regeneration.
HeartBeam Inc. Advances Toward FDA Clearance with Promising Q2 2025 Results
HeartBeam Inc. reports significant progress toward FDA clearance for its innovative 12-lead ECG synthesis software, highlighting its potential to revolutionize cardiac care outside medical facilities.